{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:21:01Z","timestamp":1789543261818,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jad-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jad.2018.07.014","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T20:31:09Z","timestamp":1531254669000},"page":"242-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders"],"prefix":"10.1016","volume":"239","author":[{"given":"S.","family":"Roat-Shumway","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.E.","family":"Wroolie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.F.","family":"Schatzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.L.","family":"Rasgon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jad.2018.07.014_bib0001","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the veterans administration genetic epidemiology study","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.jad.2018.07.014_bib0002","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00004714-200110000-00009","article-title":"Rapid reversal of psychotic depression using mifepristone","volume":"21","author":"Belanoff","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2018.07.014_bib0003","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-3223(02)01432-4","article-title":"An open label trial of C-1073 (mifepristone) for psychotic major depression","volume":"52","author":"Belanoff","year":"2002","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2018.07.014_bib0004","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/JCP.0000000000000744","article-title":"Mifepristone plasma level and glucocorticoid receptor antagonism associated with response in patients with psychotic depression","volume":"37","author":"Block","year":"2017","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2018.07.014_bib0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wad.0000213866.86934.7e","article-title":"Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications","volume":"20","author":"Craft","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"6","key":"10.1016\/j.jad.2018.07.014_bib0006","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/cen.12564","article-title":"Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome","volume":"81","author":"Crespo","year":"2014","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"10.1016\/j.jad.2018.07.014_bib0007","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jad.2018.07.014_bib0008","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.npp.1300884","article-title":"Clinical and biological effects of mifepristone treatment for psychotic depression","volume":"31","author":"Flores","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.jad.2018.07.014_bib0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ecl.2013.10.005","article-title":"Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism","volume":"43","author":"Geer","year":"2014","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.jad.2018.07.014_bib0010","series-title":"Society of Biological Psychiatry 60th Annual Scientific Convention and Meeting,","article-title":"Decreased insulin sensitivity and increased plasma insulin, glucose, and triglyceride concentrations and their interactions in remitted patients with major depression: evidence for an incipient metabolic syndrome","author":"Gold","year":"2005"},{"issue":"12 Pt 2","key":"10.1016\/j.jad.2018.07.014_bib0011","first-page":"21","article-title":"Rating depressive patients","volume":"41","author":"Hamilton","year":"1980","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.jad.2018.07.014_bib0012","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/070674371405901206","article-title":"Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment","volume":"59","author":"Lam","year":"2014","journal-title":"Can. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2018.07.014_bib0013","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neubiorev.2008.10.008","article-title":"Impairments in glucose tolerance can have a negative impact on cognitive function: a systematic research review","volume":"33","author":"Lamport","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"8","key":"10.1016\/j.jad.2018.07.014_bib0014","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molmet.2016.06.011","article-title":"Insulin in the nervous system and the mind: Functions in metabolism, memory, and mood","volume":"5","author":"Lee","year":"2016","journal-title":"Mol. Metab."},{"issue":"3","key":"10.1016\/j.jad.2018.07.014_bib0015","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.psychres.2015.10.013","article-title":"Adjuvant pioglitazone for unremitted depression: clinical correlates of treatment response","volume":"230","author":"Lin","year":"2015","journal-title":"Psychiatry Res."},{"issue":"Suppl 1","key":"10.1016\/j.jad.2018.07.014_bib0016","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neurobiolaging.2005.09.004","article-title":"Insulin resistance in depressive disorders and Alzheimer's disease: revisiting the missing link hypothesis","volume":"26","author":"Rasgon","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.jad.2018.07.014_bib0017","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mp.2016.162","article-title":"Insulin resistance-a missing link no more","volume":"21","author":"Rasgon","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2018.07.014_bib0018","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archpsyc.57.10.925","article-title":"Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders","volume":"57","author":"Sapolsky","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2018.07.014_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15386\/cjm.2014.8872.871.at1cm2","article-title":"The impact of stress and glucocorticoids on memory","volume":"87","author":"Tatomir","year":"2014","journal-title":"Clujul. Med."},{"issue":"11","key":"10.1016\/j.jad.2018.07.014_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187448","article-title":"The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women","volume":"12","author":"Webb","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jad.2018.07.014_bib0021","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1176\/ajp.147.10.1297","article-title":"Cognitive effects of corticosteroids","volume":"147","author":"Wolkowitz","year":"1990","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.014_bib0022","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpsychires.2014.10.001","article-title":"Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects","volume":"60","author":"Wroolie","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.jad.2018.07.014_bib0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/10253890500069189","article-title":"Cortisol in mood disorders","volume":"7","author":"Young","year":"2004","journal-title":"Stress"},{"issue":"8","key":"10.1016\/j.jad.2018.07.014_bib0024","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","article-title":"Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder","volume":"29","author":"Young","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.07.014_bib0025","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.12659\/MSM.895251","article-title":"Relationship between glucocorticoids and insulin resistance in healthy individuals","volume":"22","author":"Zhou","year":"2016","journal-title":"Med. Sci. Monit."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718306943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718306943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T22:16:30Z","timestamp":1533852990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718306943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":25,"alternative-id":["S0165032718306943"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.07.014","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive effects of mifepristone in overweight, euthymic adults with depressive disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}